SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-019081
Filing Date
2022-07-12
Accepted
2022-07-12 16:13:31
Documents
15
Period of Report
2022-07-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41837
2 ex99-1.htm EX-99.1 15999
3 ex99-1_001.jpg GRAPHIC 3818
  Complete submission text file 0001493152-22-019081.txt   292263

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20220712.xsd EX-101.SCH 3810
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20220712_def.xml EX-101.DEF 27210
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20220712_lab.xml EX-101.LAB 37667
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20220712_pre.xml EX-101.PRE 25831
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6033
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 221079296
SIC: 2834 Pharmaceutical Preparations